These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 39410795)

  • 1. Protein requirements in adults with phenylketonuria and bioavailability of glycomacropeptide compared to an l-amino acid-based product.
    Turki A; Stockler-Ipsiroglu S; Sirrs S; Branov J; Bosdet T; Elango R
    J Inherit Metab Dis; 2024 Oct; ():. PubMed ID: 39410795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolomic Markers of Essential Fatty Acids, Carnitine, and Cholesterol Metabolism in Adults and Adolescents with Phenylketonuria.
    Stroup BM; Nair N; Murali SG; Broniowska K; Rohr F; Levy HL; Ney DM
    J Nutr; 2018 Feb; 148(2):194-201. PubMed ID: 29490096
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differential effects of low-phenylalanine protein sources on brain neurotransmitters and behavior in C57Bl/6-Pah(enu2) mice.
    Sawin EA; Murali SG; Ney DM
    Mol Genet Metab; 2014 Apr; 111(4):452-61. PubMed ID: 24560888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Improved nutritional management of phenylketonuria by using a diet containing glycomacropeptide compared with amino acids.
    van Calcar SC; MacLeod EL; Gleason ST; Etzel MR; Clayton MK; Wolff JA; Ney DM
    Am J Clin Nutr; 2009 Apr; 89(4):1068-77. PubMed ID: 19244369
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycomacropeptide, a low-phenylalanine protein isolated from cheese whey, supports growth and attenuates metabolic stress in the murine model of phenylketonuria.
    Solverson P; Murali SG; Brinkman AS; Nelson DW; Clayton MK; Yen CL; Ney DM
    Am J Physiol Endocrinol Metab; 2012 Apr; 302(7):E885-95. PubMed ID: 22297302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dietary glycomacropeptide supports growth and reduces the concentrations of phenylalanine in plasma and brain in a murine model of phenylketonuria.
    Ney DM; Hull AK; van Calcar SC; Liu X; Etzel MR
    J Nutr; 2008 Feb; 138(2):316-22. PubMed ID: 18203898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sex differences in body composition and bone mineral density in phenylketonuria: A cross-sectional study.
    Stroup BM; Hansen KE; Krueger D; Binkley N; Ney DM
    Mol Genet Metab Rep; 2018 Jun; 15():30-35. PubMed ID: 30023287
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tyrosine requirements in children with classical PKU determined by indicator amino acid oxidation.
    Bross R; Ball RO; Clarke JT; Pencharz PB
    Am J Physiol Endocrinol Metab; 2000 Feb; 278(2):E195-201. PubMed ID: 10662702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet.
    Solverson P; Murali SG; Litscher SJ; Blank RD; Ney DM
    PLoS One; 2012; 7(9):e45165. PubMed ID: 23028819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nutritional status in patients with phenylketonuria using glycomacropeptide as their major protein source.
    Pinto A; Almeida MF; Ramos PC; Rocha S; Guimas A; Ribeiro R; Martins E; Bandeira A; MacDonald A; Rocha JC
    Eur J Clin Nutr; 2017 Oct; 71(10):1230-1234. PubMed ID: 28402322
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolomic Insights into the Nutritional Status of Adults and Adolescents with Phenylketonuria Consuming a Low-Phenylalanine Diet in Combination with Amino Acid and Glycomacropeptide Medical Foods.
    Stroup BM; Ney DM; Murali SG; Rohr F; Gleason ST; van Calcar SC; Levy HL
    J Nutr Metab; 2017; 2017():6859820. PubMed ID: 29464117
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycomacropeptide: long-term use and impact on blood phenylalanine, growth and nutritional status in children with PKU.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Jackson R; Gingell C; Rocha J; Van Spronsen FJ; MacDonald A
    Orphanet J Rare Dis; 2019 Feb; 14(1):44. PubMed ID: 30770754
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Effect of Glycomacropeptide versus Amino Acids on Phenylalanine and Tyrosine Variability over 24 Hours in Children with PKU: A Randomized Controlled Trial.
    Daly A; Evans S; Chahal S; Santra S; Pinto A; Gingell C; Rocha JC; van Spronsen F; Jackson R; MacDonald A
    Nutrients; 2019 Feb; 11(3):. PubMed ID: 30823411
    [No Abstract]   [Full Text] [Related]  

  • 14. The Indicator Amino Acid Oxidation Method with the Use of l-[1-13C]Leucine Suggests a Higher than Currently Recommended Protein Requirement in Children with Phenylketonuria.
    Turki A; Ueda K; Cheng B; Giezen A; Salvarinova R; Stockler-Ipsiroglu S; Elango R
    J Nutr; 2017 Feb; 147(2):211-217. PubMed ID: 28053173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycomacropeptide for nutritional management of phenylketonuria: a randomized, controlled, crossover trial.
    Ney DM; Stroup BM; Clayton MK; Murali SG; Rice GM; Rohr F; Levy HL
    Am J Clin Nutr; 2016 Aug; 104(2):334-45. PubMed ID: 27413125
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutritional management of PKU with glycomacropeptide from cheese whey.
    Ney DM; Gleason ST; van Calcar SC; MacLeod EL; Nelson KL; Etzel MR; Rice GM; Wolff JA
    J Inherit Metab Dis; 2009 Feb; 32(1):32-9. PubMed ID: 18956251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Breakfast with glycomacropeptide compared with amino acids suppresses plasma ghrelin levels in individuals with phenylketonuria.
    MacLeod EL; Clayton MK; van Calcar SC; Ney DM
    Mol Genet Metab; 2010 Aug; 100(4):303-8. PubMed ID: 20466571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolomic changes demonstrate reduced bioavailability of tyrosine and altered metabolism of tryptophan via the kynurenine pathway with ingestion of medical foods in phenylketonuria.
    Ney DM; Murali SG; Stroup BM; Nair N; Sawin EA; Rohr F; Levy HL
    Mol Genet Metab; 2017 Jun; 121(2):96-103. PubMed ID: 28400091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Purification and use of glycomacropeptide for nutritional management of phenylketonuria.
    Laclair CE; Ney DM; MacLeod EL; Etzel MR
    J Food Sci; 2009; 74(4):E199-206. PubMed ID: 19490325
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Food products made with glycomacropeptide, a low-phenylalanine whey protein, provide a new alternative to amino Acid-based medical foods for nutrition management of phenylketonuria.
    van Calcar SC; Ney DM
    J Acad Nutr Diet; 2012 Aug; 112(8):1201-10. PubMed ID: 22818728
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.